0000939767-20-000074.txt : 20200508 0000939767-20-000074.hdr.sgml : 20200508 20200508211837 ACCESSION NUMBER: 0000939767-20-000074 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200508 FILED AS OF DATE: 20200508 DATE AS OF CHANGE: 20200508 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PAPADOPOULOS STELIOS CENTRAL INDEX KEY: 0001202098 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-30235 FILM NUMBER: 20862369 MAIL ADDRESS: STREET 1: 3 SOMERSET DRIVE SOUTH CITY: GREAT NECK STATE: NY ZIP: 11020 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: EXELIXIS, INC. CENTRAL INDEX KEY: 0000939767 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 043257395 STATE OF INCORPORATION: DE FISCAL YEAR END: 0101 BUSINESS ADDRESS: STREET 1: 1851 HARBOR BAY PARKWAY CITY: ALAMEDA STATE: CA ZIP: 94502 BUSINESS PHONE: 6508377000 MAIL ADDRESS: STREET 1: 1851 HARBOR BAY PARKWAY CITY: ALAMEDA STATE: CA ZIP: 94502 FORMER COMPANY: FORMER CONFORMED NAME: EXELIXIS INC DATE OF NAME CHANGE: 20000207 FORMER COMPANY: FORMER CONFORMED NAME: EXELIXIS PHARMACEUTICALS INC DATE OF NAME CHANGE: 20000106 4 1 wf-form4_158898709740775.xml FORM 4 X0306 4 2020-05-08 0 0000939767 EXELIXIS, INC. EXEL 0001202098 PAPADOPOULOS STELIOS C/O EXELIXIS, INC. 1851 HARBOR BAY PARKWAY ALAMEDA CA 94502 1 0 0 0 Common Stock 2020-05-08 4 M 0 30000 4.58 A 1082568 D Common Stock 2020-05-08 4 M 0 15000 5.92 A 1097568 D Common Stock 2020-05-08 4 S 0 45000 25.84 D 1052568 D Option (right to buy) 4.58 2020-05-08 4 M 0 30000 0 D 2013-05-23 2020-05-22 Common Stock 30000.0 0 D Option (right to buy) 5.92 2020-05-08 4 M 0 15000 0 D 2010-05-19 2020-05-18 Common Stock 15000.0 0 D Includes 10,317 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $25.78 to $25.93. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4. The option, representing the right to purchase a total of 30,000 shares of Exelixis, Inc. common stock, became fully exercisable on May 23, 2013. The option, representing the right to purchase a total of 15,000 shares of Exelixis, Inc. common stock, became fully exercisable on May 19, 2010. /s/ Jennifer Drimmer Rokovich, Attorney in Fact 2020-05-08